Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 9/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | TYMS | P04818 | 2/20 | 0.74 |
| ▸ | POLB | P06746 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
| ▸ | GAA | P10253 | 1/20 | 0.74 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.74 |
| ▸ | TLR4 | O00206 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | GLA | P06280 | 1/20 | 0.71 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminopterin SCHEMBL9514067 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL20769794 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL1626034 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL8887 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL8161477 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL29398079 | 1.00 | DHFR (0.76) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL23581239 | 0.99 | DHFR (0.75) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL5024596 | 0.99 | DHFR (0.75) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL2504074 | 0.99 | DHFR (0.75) | DHFRKDM4EMEN1ALDH1A1TYMS | |
| Aminopterin SCHEMBL2387187 | 0.99 | DHFR (0.75) | DHFRKDM4EMEN1ALDH1A1TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119942708-A | Intelligent monitoring system based on intelligent industrial park | 苏州烁永信息科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-118890013-A | Multimode programmable gain amplifier suitable for high-precision analog front end | 电子科技大学 | 2024-11-01 | — | — | CN | claimed |
| CN-116830168-A | Dynamic vision sensing system with static capture mode | 香港应用科技研究院有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-4090685-A1 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE | TrueBinding, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| CN-114231042-B | Graft copolymer, medicine-carrying assembly thereof and preparation method | 北京化工大学 | 2022-08-30 | — | — | CN | claimed |
| CN-114685585-A | Nucleotide sequence, double-stranded oligonucleotide, pharmaceutical composition and conjugate, and preparation method and application thereof | 苏州瑞博生物技术股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114231042-A | Graft copolymer, medicine-carrying assembly thereof and preparation method | 北京化工大学 | 2022-03-25 | — | — | CN | claimed |
| US-12624354-B2 | Methods and compositions for prime editing nucleotide sequences | THE BROAD INSTITUTE, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12624353-B2 | Methods and compositions for prime editing nucleotide sequences | THE BROAD INSTITUTE, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12570972-B2 | Methods and compositions for prime editing nucleotide sequences | THE BROAD INSTITUTE, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12565660-B2 | Immunomodulating transgenic plants and related methods | AGRIVIDA, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260055281-A1 | ANTIBACTERIAL WATER-BASED PAINT THAT IS ACTIVATED BY METALLIC NANOPARTICLES | FLUOINK NANOTECHNOLOGIES (TN) | 2026-02-26 | — | — | US | disclosed |
| CN-118890013-B | Multimode programmable gain amplifier suitable for high-precision analog front end | 电子科技大学 | 2026-01-06 | — | — | CN | disclosed |
| CN-114746105-A | IL-15 compositions and methods of use thereof | 普罗维瓦疗法香港有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114685585-A | Nucleotide sequence, double-stranded oligonucleotide, pharmaceutical composition and conjugate, and preparation method and application thereof | 苏州瑞博生物技术股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114664429-A | Method for detecting benign and malignant breast tumor and application thereof | 上海爱谱蒂康生物科技有限公司 | 2022-06-24 | — | — | CN | disclosed |
| WO-2022106365-A1 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | SEDERMA (FR) | 2022-05-27 | — | — | WO | disclosed |
| CN-109504661-B | Antigen-specific T lymphocyte hybridoma and preparation method and application thereof | 上海昀怡健康科技发展有限公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114231042-A | Graft copolymer, medicine-carrying assembly thereof and preparation method | 北京化工大学 | 2022-03-25 | — | — | CN | disclosed |
| CN-111315008-B | Communication time sequence setting method for control station and mobile station | 东南大学 | 2022-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624354-B2 | Methods and compositions for prime editing nucleotide sequences | POLM, FEN1, SSU72 | DHFR 591/4885KDM4E 3044/4885MEN1 4385/4885 |
| US-20260055281-A1 | ANTIBACTERIAL WATER-BASED PAINT THAT IS ACTIVATED BY METALLIC NANOPARTICLES | CD44, CD47, CD4 | DHFR 3612/4885KDM4E 3115/4885MEN1 4203/4885 |
| US-12624353-B2 | Methods and compositions for prime editing nucleotide sequences | RNGTT, FEN1, POLB | DHFR 456/4885KDM4E 2634/4885MEN1 4350/4885 |
| US-12565660-B2 | Immunomodulating transgenic plants and related methods | SET, IL2, IL2RA | DHFR 2904/4885KDM4E 2560/4885MEN1 4594/4885 |
| US-12570972-B2 | Methods and compositions for prime editing nucleotide sequences | RNGTT, FEN1, POLM | DHFR 282/4885KDM4E 3239/4885MEN1 4249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.